Plasmapherese und Immunadsorption auf der Intensivstation

Ataman K, Jehmlich M, Kock S et al (2002) Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock. Intensive Care Med 28:1164–1167 Barzilay E, Kessler D, Berlot G et al (1989) Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 17:634–637 Berrouschot J, Baumann I, Kalischewski P et al (1997) Therapy of myasthenic crisis. Crit Care Med 25:1228–1235 Busund R, Koukline V, Utrobin U, Nedashkovsky E (2002) Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 28:1434–1439 Dorffel WV, Felix SB, Wallukat G et al (1997) Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 95:1994–1997 Galldiks N, Dohmen C, Neveling M et al (2009) Selective immune adsorption treatment of severe Guillain Barre syndrome in the intensive care unit. Neurocrit Care [Epub ahead of print] Gaubitz M, Seidel M, Kummer S et al (1998) Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus. J Autoimmun 11:495–501 George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354:1927–1935 Jayne DR, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188 Klemmer PJ, Chalermskulrat W, Reif MS et al (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42:1149–1153 Laczika K, Knapp S, Derfler K et al (2000) Immunoadsorption in Goodpasture’s syndrome. Am J Kidney Dis 36:392–395 Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033–1042 Lewis EJ, Hunsicker LG, Lan SP et al (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med 326:1373–1379 Liu JF, Wang WX, Xue J et al (Hrsg) Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis. Ther Apher Dial 14:153–160 Mannucci PM, Peyvandi F (2009) Autoimmune hemophilia at rescue. Haematologica 94:459–461 Michael M, Elliott EJ, Craig JC et al (2009) Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis 53:259–272 Moldenhauer A, Haas J, Wascher C et al (2005) Immunoadsorption patients with multiple sclerosis: an open-label pilot study. Eur J Clin Invest 35:523–530 Muller J, Wallukat G, Dandel M et al (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385–391 Pagnoux C, Korach JM, Guillevin L (2005) Indications for plasma exchange in systemic lupus erythematosus in 2005. Lupus 14:871–877 Raphael JC, Chastang C, Masson C et al (1985) Guillain-Barre syndrome and plasma exchange. Lancet 2:45 Ronco C, Brendolan A, Lonnemann G et al (2002) A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30:1250–1255 Schefold JC, Haehling S von, Corsepius M et al (2007) A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a. Shock 28:418–425 Schmaldienst S, Goldammer A, Spitzauer S et al (2000) Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption. Am J Kidney Dis 36:490–497 Stegmayr BG, Almroth G, Berlin G et al (1999) Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs 22:81–87 Meche FG van der, Schmitz PI (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 326:1123–1129 Viertel A, Weidmann E, Wigand R et al (2000) Treatment of severe systemic lupus erythematosus with immunoadsorption and intravenous immunoglobulins. Intensive Care Med 26:823–824 Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia gravis. Lancet 357:2122–2128 Weinshenker BG, O’Brien PC, Petterson TM et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878–886 Wenning W, Haghikia A, Laubenberger J et al (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080 Zeitler H, Ulrich-Merzenich G, Hess L et al (2005) Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. Blood 105:2287–2293